(Q34254356)

English

Matrix metalloproteinases and angiogenic factors: predictors of survival after radical prostatectomy for clinically organ-confined prostate cancer?

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Matrix metalloproteinases and angiogenic factors: predictors of survival after radical prostatectomy for clinically organ-confined prostate cancer? (English)

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

prostate cancer

1 reference

based on heuristic

inferred from title

Ruslan Hlushchuk

object named as

Ruslan Hlushchuk

4

0 references

object named as

Ulrike Held

6

0 references

author name string

Silvan Boxler

1

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Valentin Djonov

2

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Thomas M Kessler

3

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Lucas M Bachmann

5

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Regula Markwalder

7

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

George N Thalmann

8

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

language of work or name

0 references

publication date

1 October 2010

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

The American Journal of Pathology

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

177

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

2216-2224

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Matrix metalloproteinases as novel biomarkers and potential therapeutic targets in human cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2966781

6 July 2018

Screening and prostate-cancer mortality in a randomized European study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2966781

6 July 2018

Cancer statistics, 2008

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2966781

6 July 2018

Should the Gleason grading system for prostate cancer be modified to account for high-grade tertiary components? A systematic review and meta-analysis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2966781

6 July 2018

Matrix metalloproteinases: roles in cancer and metastasis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2966781

6 July 2018

Tumstatin, the NC1 domain of alpha3 chain of type IV collagen, is an endogenous inhibitor of pathological angiogenesis and suppresses tumor growth

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2966781

6 July 2018

Expression of matrix metalloproteinase (MMP)-2 and MMP-9 in breast cancer with a special reference to activator protein-2, HER2, and prognosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2966781

6 July 2018

Expression of pro-angiogenic growth factors VEGF, EGF and bFGF and their topographical relation to neovascularisation in prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2966781

6 July 2018

A novel antisense inhibitor of MMP-9 attenuates angiogenesis, human prostate cancer cell invasion and tumorigenicity.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2966781

6 July 2018

Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2966781

6 July 2018

Imbalance between expression of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in invasiveness and metastasis of human gastric carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2966781

6 July 2018

Fibroblast growth factors and their receptors in urological cancers: basic research and clinical implications

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2966781

6 July 2018

Clinical application of antiangiogenic therapy: microvessel density, what it does and doesn't tell us.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2966781

6 July 2018

Tissue microarray sampling strategy for prostate cancer biomarker analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2966781

6 July 2018

Tissue microarray (TMA) technology: miniaturized pathology archives for high-throughput in situ studies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2966781

6 July 2018

Under staging and under grading in a contemporary series of patients undergoing radical prostatectomy: results from the Cancer of the Prostate Strategic Urologic Research Endeavor database.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2966781

6 July 2018

Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2966781

6 July 2018

Vascular endothelial growth factor expression and capillary architecture in high-grade PIN and prostate cancer in untreated and androgen-ablated patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2966781

6 July 2018

Relative expression of type IV collagenase, E-cadherin, and vascular endothelial growth factor/vascular permeability factor in prostatectomy specimens distinguishes organ-confined from pathologically advanced prostate cancers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2966781

6 July 2018

The matrix metalloproteinase stromelysin-1 acts as a natural mammary tumor promoter

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2966781

6 July 2018

Overexpression of hypoxia-inducible factor 1alpha in common human cancers and their metastases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2966781

6 July 2018

Localization and quantification of mRNA for matrix metalloproteinase-2 (MMP-2) and tissue inhibitor of matrix metalloproteinase-2 (TIMP-2) in human benign and malignant prostatic tissue.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2966781

6 July 2018

The stromal proteinase MMP3/stromelysin-1 promotes mammary carcinogenesis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2966781

6 July 2018

Increased matrix metalloproteinase-9 secretion in short-term tissue cultures of prostatic tumor cells.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2966781

6 July 2018

Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2966781

6 July 2018

Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2966781

6 July 2018

Long-Term (15 Years) Results After Radical Prostatectomy For Clinically Localized (Stage T2c Or Lower) Prostate Cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2966781

6 July 2018

Proliferation of immature tumor vessels is a novel marker of clinical progression in prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2966781

28 October 2018

Activation of the osteopontin/matrix metalloproteinase-9 pathway correlates with prostate cancer progression.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2966781

28 October 2018

Prostate cancer and the Will Rogers phenomenon.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2966781

28 October 2018

A protective role for matrix metalloproteinase-3 in squamous cell carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2966781

28 October 2018

Expression and activity of matrix metalloproteinases-2 and -9 in serum, core needle biopsies and tissue specimens of prostate cancer patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2966781

28 October 2018

Up-regulation of hypoxia-inducible factor 1alpha is an early event in prostate carcinogenesis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2966781

28 October 2018

Sample-size calculations for the Cox proportional hazards regression model with nonbinary covariates

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2966781

28 October 2018

Cancer Control and Quality of Life Following Anatomical Radical Retropubic Prostatectomy: Results at 10 Years

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2966781

28 October 2018

Microvessel density in prostate carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/20889560

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic significance of matrix metalloproteinase 2 and tissue inhibitor of metalloproteinase 2 expression in prostate cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/20889560

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Characterization of expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in prostate cancer cell lines

1 reference

https://pubmed.ncbi.nlm.nih.gov/20889560

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Expression of bFGF, VEGF and c-met and their correlation with microvessel density and progression in prostate carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/20889560

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The use of prostate specific antigen, clinical stage and Gleason score to predict pathological stage in men with localized prostate cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/20889560

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/20889560

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Predictors of pathologic stage in prostatic carcinoma. The role of neovascularity

1 reference

https://pubmed.ncbi.nlm.nih.gov/20889560

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

5-Year Tumor Recurrence Rates After Anatomical Radical Retropubic Prostatectomy For Prostate Cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/20889560

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunohistochemical studies of activated matrix metalloproteinase-2 (MMP-2a)expression in human prostate cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/20889560

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional update

1 reference

https://pubmed.ncbi.nlm.nih.gov/20889560

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tumor angiogenesis is associated with progression after radical prostatectomy in pT2/pT3 prostate cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/20889560

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Independent prognostic importance of microvessel density in clinically localized prostate cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/20889560

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

MMP-19: cellular localization of a novel metalloproteinase within normal breast tissue and mammary gland tumours

1 reference

https://pubmed.ncbi.nlm.nih.gov/20889560

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In situ hybridization studies of metalloproteinases 2 and 9 and TIMP-1 and TIMP-2 expression in human prostate cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/20889560

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Expression of matrix metalloproteinase-7 and tissue inhibitor of metalloproteinase-1 in human prostate

1 reference

https://pubmed.ncbi.nlm.nih.gov/20889560

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Matrix metalloproteinases generate angiostatin: effects on neovascularization

1 reference

https://pubmed.ncbi.nlm.nih.gov/20889560

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Osteopontin: possible role in prostate cancer progression

1 reference

https://pubmed.ncbi.nlm.nih.gov/20889560

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Matrix metalloproteinases as diagnostic (MMP-13) and prognostic (MMP-2, MMP-9) markers of prostate cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/20889560

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Matrix metalloproteinases and angiogenesis

1 reference

https://pubmed.ncbi.nlm.nih.gov/20889560

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

EAU guidelines on prostate cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/20889560

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tissue microarray analysis of hMSH2 expression predicts outcome in men with prostate cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/20889560

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Expression of bFGF/FGFR-1 and vascular proliferation related to clinicopathologic features and tumor progress in localized prostate cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/20889560

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Nerve-sparing open radical retropubic prostatectomy

1 reference

https://pubmed.ncbi.nlm.nih.gov/20889560

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The expression of vascular endothelial growth factor is associated with the risk of cancer progression after radical prostatectomy

1 reference

https://pubmed.ncbi.nlm.nih.gov/20889560

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Matrix metalloproteinase-19 is a predictive marker for tumor invasiveness in patients with oropharyngeal squamous cell carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/20889560

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Matrix metalloproteinase-9 (MMP-9) immunoreactive protein in urinary bladder cancer: a marker of favorable prognosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/20889560

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The prognostic value of vascular endothelial growth factor (VEGF)-A and its receptor in clinically localized prostate cancer: a prospective evaluation in 100 patients undergoing radical prostatectomy

1 reference

https://pubmed.ncbi.nlm.nih.gov/20889560

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.2353/AJPATH.2010.091190

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34254356&oldid=1856145560"